BARNSLEY Hospital has been shortlisted for an award for its work towards studying the prevention of blood clotting.
The hospital worked in partnership with Sky to carry out an observational study into preventing blood clots in high-risk pregnant patients.
The study was conducted on 90 patients who were prescribed a new newumuscular electrostimulation device called geko, to help increase blood flow and prevent blood clots.
Following the study Barnsley became the first maternity unit in the UK to adopt the innovative geko device, and two other hospitals have since followed.
Bernard Ross, CEO of Sky Medical Technology, comments: “It’s fantastic to be shortlisted in such a well-respected awards alongside a range of truly innovative healthcare projects.
"This shortlisting is a testament to the hard work of the entire team at Barnsley Hospital NHS Foundation Trust Maternity Unit and their willingness to trial and ultimately embrace the geko device.”
